The Pharma Letter

The week in pharma: action, reaction and insight – week to October 24

Among last week’s significant news, US biotech Veridian Therapeutics announced it has entered into a royalty financing ...
The Pharma Letter

MHRA approves Alhemo to prevent or reduce bleeding episode frequency

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine Alhemo (concizumab) to prevent or ...
The Pharma Letter

Cipla and Eli Lilly partner to launch tirzepatide as Yurpeak in India

Indian drugmaker Cipla Limited has entered into a strategic marketing and distribution agreement with US pharma major Eli ...
The Pharma Letter

Lilly to expand gene therapy portfolio with buy of Adverum

US pharma major Eli Lilly shares closed up 2.8%, while those of Adverum Biotechnologies dropped 2.4% to $4.28, on news of a ...